ArticleCureus2026
Epidemiology and Short-Term Outcomes of Acute Coronary Syndrome in a Nigerian Tertiary Hospital: A Prospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute coronary syndrome (ACS) is associated with significant morbidity and mortality, with outcomes influenced by disease subtype and patient comorbidities. Data on the epidemiology and outcomes of ACS in Nigeria remain limited.
objectivesThis study aimed to describe the epidemiological characteristics, clinical presentation, and short-term outcomes of patients with ACS in a Nigerian tertiary hospital.
methodsThis was a prospective cohort study conducted at the University of Benin Teaching Hospital (UBTH), Benin City, Nigeria, from May 11, 2022, to May 10, 2023. Thirty adult patients (n = 30) aged ≥18 years with a confirmed diagnosis of ACS were consecutively recruited and followed for three months. Data on sociodemographic characteristics, cardiovascular risk factors, clinical features, electrocardiographic and echocardiographic findings, and treatment outcomes were collected. Statistical analysis was performed using SPSS version 27 (IBM Corp., Armonk, NY), with statistical significance set at p < 0.05.
resultsThe mean age of the patients was 59.0 ± 14.2 years, with the majority aged ≥60 years (19 patients, 63.3%). There were 20 male patients (66.7%) and 10 female patients (33.3%). The most prevalent cardiovascular risk factor was hypertension (22 patients, 73.3%), followed by alcohol intake (12 patients, 40%), dyslipidemia (six patients, 20%), and diabetes mellitus (five patients, 16.7%). ST-segment elevation myocardial infarction (STEMI) was the most common ACS subtype (16 patients, 53.3%), followed by unstable angina (nine patients, 30%) and non-ST-segment elevation myocardial infarction (NSTEMI) (five patients, 16.7%). Overall mortality was seven patients (23.3%), comprising in-hospital deaths in five patients (16.7%) and out-of-hospital deaths within three months in two patients (6.7%). Mortality was higher among patients aged ≥60 years (six of seven deaths, 85.7%) and among those with STEMI (six of seven deaths, 85.7%). Elevated cardiac troponin T levels were significantly associated with increased mortality (seven of seven deaths, 100%, p = 0.010).
conclusionAcute coronary syndrome predominantly affected older male patients, with hypertension and alcohol use being the most common risk factors. STEMI was the most frequent presentation and accounted for most deaths. The high short-term mortality rate in the index study underscores the need for improved early diagnosis, risk factor modification, and access to timely reperfusion therapies to improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.